Sciabolacci, S., Ruggeri, L., Cardinali, V., Brunetti, L., Tricarico, S., Saldi, S., . . . Pierini, A. (2022). P574: CPX-351 COMBINED WITH HEMATOPOIETIC CELL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY FOR HIGH-RISK ACUTE MYELOID LEUKEMIA. Wiley.
Chicago Style (17th ed.) CitationSciabolacci, S., et al. P574: CPX-351 COMBINED WITH HEMATOPOIETIC CELL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY FOR HIGH-RISK ACUTE MYELOID LEUKEMIA. Wiley, 2022.
MLA (9th ed.) CitationSciabolacci, S., et al. P574: CPX-351 COMBINED WITH HEMATOPOIETIC CELL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY FOR HIGH-RISK ACUTE MYELOID LEUKEMIA. Wiley, 2022.
Warning: These citations may not always be 100% accurate.